EMA accepts USV’s marketing authorisation application of proposed biosimilar Pegfilgrastim
Pegfilgrastim reduces the duration of Neutropenia and decreases the chances of infection
Author
Five ways to address talent challenges
The pharma industry is finding it difficult to source and retain its existing talent pool. Thammaiah BN, MD, Kelly Services India,…
AYUSH industry may create 25 mn jobs by 2020
According to Suresh Prabhu, Union minister of Commerce and Industry, the government is eyeing a three-fold increase in the AYUSH…
US FDA approves Mylan and Biocon’s Ogivri
It is the first biosimilar for Trastuzumab, for the treatment of HER2-Positive breast and gastric cancers
Glenmark to market respiratory product in Nordic countries
The company added that the commercialisation of the product would depend on national approval as well as substitution and pricing…
Zydus Pharmaceuticals (USA) receives US FDA approval
The drug is used for the management of certain kinds of seizures, nerve pain and fibromyalgia
DRL gets approval for Impoyz Cream
The drug is a high potency topical steroid approved for the treatment of moderate to severe plaque psoriasis in patients 18 years…
International Arogya 2017 to be held in Delhi
Jointly organised by Government of India, FICCI and Pharmexcil, the event, from December 4-7, 2017, will have exhibitions and…
Cipla launches Q-TIB globally
Q-TIB will help prevent tuberculosis infection in people living with HIV